Profil
Dayan Colin is currently the Chair of Clinical Diabetes and Metabolism and Head at the University of Cardiff, as well as a Partner and Advisor at JDRF T1D Fund.
Previously, he was the Director at the Institute of Molecular Immunology.
Mr. Colin received a doctorate degree from University College Oxford.
Aktive Positionen von Dayan Colin
| Unternehmen | Position | Beginn |
|---|---|---|
JDRF T1D Fund
 JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | Berater | - |
| University of Cardiff | Vorsitzender | - |
Ehemalige bekannte Positionen von Dayan Colin
| Unternehmen | Position | Ende |
|---|---|---|
| Institute of Molecular Immunology | Direktor/Vorstandsmitglied | - |
Ausbildung von Dayan Colin
| University College Oxford | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
| Institute of Molecular Immunology | |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | Finance |
